Novoste to begin selling new radiation treatment in Europe
This article was originally published in Clinica
Executive Summary
US firm Novoste announced at the European Society of Cardiology meeting in Vienna last week that it will begin selling its Beta-Cath intracoronary radiation therapy device in Europe by the end of this year. This will be the first time anywhere in the world that a coronary radiation treatment for restenosis is available.